Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals
Autor: | seyedeh somayeh hosseini alarzi, Hamidreza Joshaghani, Sara Hosseinzadeh, Nafiseh Abdolahi, Alireza Norouzi, Ommolbanin Younesian, Nasser Behnampour, Behnaz Khodabakhshi |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Endocrinology Diabetes and Metabolism Clinical Biochemistry chemistry.chemical_element Disease 010501 environmental sciences 01 natural sciences Biochemistry Gastroenterology Article Inorganic Chemistry Selenium 03 medical and health sciences Immune system Selenium deficiency Diabetes mellitus Internal medicine medicine Humans Micronutrient Micronutrients Immune response Risk factor Respiratory system Pandemics Aged 0105 earth and related environmental sciences Inflammation 0303 health sciences SARS-CoV-2 business.industry 030302 biochemistry & molecular biology Biochemistry (medical) COVID-19 General Medicine medicine.disease chemistry business |
Zdroj: | Biological Trace Element Research |
ISSN: | 1559-0720 0163-4984 |
DOI: | 10.1007/s12011-021-02797-w |
Popis: | Background Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the cause of the COVID-19 pandemic and is the cause of increased mortality, especially among elderly patients and those who have severe complications, such as chronic pulmonary obstruction, hypertension, diabetes, and cancer. Nutrition, especially micronutrients, plays an important role in reducing mortality and complications from COVID-19 because micronutrients strengthen our immune system and nutritional status is an important factor that affects the outcome of patients with COVID-19. Among micronutrients, selenium has an important effect on both intrinsic and acquired immunity. Host selenium deficiency affects the viral genome and increases the virulence of viruses. We have investigated the serum selenium levels in COVID-19 patients and healthy control individuals. Methods A total of 50 patients with COVID-19 infection were included in this study. During hospitalization, 13 patients died (non-survivor group) and 37 patients recovered (survivor group). We assessed the serum selenium levels in 50 COVID-19 patients and 50 healthy individuals by Agilent SpectrAA-240 Z atomic absorption spectrometer. Results The serum selenium level was significantly lower in COVID-19 patients (77. 8 ± 13.9 μg/L) as compared to healthy control individuals (91.7 ± 16.7 μg/L), but there was no significant difference between the survivor and non-survivor groups. Also, there was no significant relationship between serum selenium levels and laboratory findings of COVID-19 patients. Conclusions These results suggest that decreased serum selenium levels may be a risk factor for the COVID-19 infection, but there was no significant relationship between selenium and severity and mortality of COVID-19 disease. |
Databáze: | OpenAIRE |
Externí odkaz: |